Clinical Trial

Reliability of Myoton in Evaluating Skin Biomechanics in Breast Cancer-Related Lymphedema

Study acronym: MYOLYMPH
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the intra- and inter-rater reliability of the MyotonPRO, a handheld device that measures the viscoelastic properties of the skin, in patients with breast cancer-related lymphedema. Twenty women with unilateral upper extremity lymphedema will be included. Each participant will undergo repeated skin assessments using the MyotonPRO by two independent raters. Additionally, ultrasonographic tissue characteristics and limb volume measurements will be performed. The findings are expected to contribute to the validation of the MyotonPRO for use in clinical lymphedema evaluation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-18.
Trial Details
NCT Number NCT07086053
Lead Sponsor Kahramanmaras Sutcu Imam University
Collaborators: Fatih Sultan Mehmet Training and Research Hospital
Conditions Breast Cancer-Related Lymphedema
Enrollment 20 participants
Start Date 2025-08-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-28